The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis
- 1 February 2006
- journal article
- Published by Elsevier in Human Pathology
- Vol. 37 (2) , 190-197
- https://doi.org/10.1016/j.humpath.2005.10.007
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathyBritish Journal of Dermatology, 2008
- Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene ExpressionJournal of Biological Chemistry, 2001
- Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopyRheumatology, 2000
- Vascular endothelial growth factor (VEGF) and its receptorsThe FASEB Journal, 1999
- ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESSClinical and Experimental Pharmacology and Physiology, 1999
- Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.Journal of Clinical Investigation, 1996
- Sequential dermal microvascular and perivascular changes in the development of sclerodermaThe Journal of Pathology, 1992
- Systemic sclerosis: a collagen or microvascular disease?BMJ, 1984
- Capillary alterations in sclerodermaJournal of the American Academy of Dermatology, 1980
- Diagnostic potential of in vivo capillary microscopy in scleroderma and related disordersArthritis & Rheumatism, 1980